Pharming submits application to FDA for RUCONEST to treat HAE
Pharming Group announced that it has submitted a supplemental Biologics License Application (BLA) to the U.S. Food and Drug Administration for RUCONEST for routine prophylaxis to…
Read More...
Read More...